Jeff Peng

1.0k total citations
7 papers, 774 citations indexed

About

Jeff Peng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jeff Peng has authored 7 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Jeff Peng's work include RNA modifications and cancer (2 papers), Peptidase Inhibition and Analysis (2 papers) and Connective tissue disorders research (2 papers). Jeff Peng is often cited by papers focused on RNA modifications and cancer (2 papers), Peptidase Inhibition and Analysis (2 papers) and Connective tissue disorders research (2 papers). Jeff Peng collaborates with scholars based in United States, United Kingdom and Spain. Jeff Peng's co-authors include Francesca Massi, Jonathan P. Lee, John E. Straub, John H. Bushweller, Nancy A. Speck, Ivano Bertini, Thomas Leroy James, Maurizio Pellecchia, Wolfgang Jahnke and David Cowburn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and Biophysical Journal.

In The Last Decade

Jeff Peng

7 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Peng United States 6 597 164 97 90 83 7 774
Benjamin R. Bowen United States 18 875 1.5× 136 0.8× 53 0.5× 57 0.6× 112 1.3× 25 1.2k
Kenji Kamata Japan 16 831 1.4× 100 0.6× 81 0.8× 101 1.1× 75 0.9× 24 1.3k
Amaury E. Fernández‐Montalván Germany 19 1.0k 1.7× 82 0.5× 79 0.8× 36 0.4× 185 2.2× 38 1.3k
Austin Vogt United States 11 517 0.9× 52 0.3× 97 1.0× 33 0.4× 57 0.7× 19 768
Marc Adler United States 19 649 1.1× 129 0.8× 109 1.1× 46 0.5× 136 1.6× 35 1.1k
Aviv Paz Israel 18 594 1.0× 63 0.4× 92 0.9× 79 0.9× 92 1.1× 39 936
Joseph Rahuel Switzerland 18 896 1.5× 116 0.7× 141 1.5× 57 0.6× 236 2.8× 24 1.4k
Clarissa G. Jakob United States 17 594 1.0× 238 1.5× 91 0.9× 22 0.2× 158 1.9× 23 1.0k
Ulrich Hassiepen Switzerland 16 997 1.7× 83 0.5× 73 0.8× 38 0.4× 427 5.1× 32 1.3k
Kevin R. Kupcho United States 10 481 0.8× 37 0.2× 40 0.4× 23 0.3× 104 1.3× 22 707

Countries citing papers authored by Jeff Peng

Since Specialization
Citations

This map shows the geographic impact of Jeff Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Peng more than expected).

Fields of papers citing papers by Jeff Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Peng. The network helps show where Jeff Peng may publish in the future.

Co-authorship network of co-authors of Jeff Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Peng. A scholar is included among the top collaborators of Jeff Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Peng. Jeff Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bullens, Sherry, Florence Lorget, Sean Bell, et al.. (2015). Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3–Related Dwarfism. Journal of Pharmacology and Experimental Therapeutics. 353(1). 132–149. 88 indexed citations
2.
Lorget, Florence, Nabil Kaci, Jeff Peng, et al.. (2012). Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia. The American Journal of Human Genetics. 91(6). 1108–1114. 140 indexed citations
3.
Pellecchia, Maurizio, Ivano Bertini, David Cowburn, et al.. (2008). Perspectives on NMR in drug discovery: a technique comes of age. Nature Reviews Drug Discovery. 7(9). 738–745. 301 indexed citations
4.
Egnor, Michael, et al.. (2006). Pressure phase relationships between carotid arterial pressure and intracranial pressure: the 'violin' analogy of intracranial pulsations. SHILAP Revista de lepidopterología. 3(S1). 1 indexed citations
5.
Massi, Francesca, Jeff Peng, Jonathan P. Lee, & John E. Straub. (2001). Simulation Study of the Structure and Dynamics of the Alzheimer’s Amyloid Peptide Congener in Solution. Biophysical Journal. 80(1). 31–44. 110 indexed citations
6.
Berardi, Marcelo J., Chaohong Sun, Frits Abildgaard, et al.. (1999). The Ig fold of the core binding factor α Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains. Structure. 7(10). 1247–1256. 70 indexed citations
7.
Bushweller, John H., et al.. (1999). Solution structure of core binding factor beta and map of the CBF alpha binding site.. Nature Structural Biology. 6(7). 624–627. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026